QT
STRO icon

Quantbot Technologies’s Sutro Biopharma STRO Stock Holding History

Quantbot Technologies’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-210
Closed -$11.9K – 1891
2024
Q1 		$11.9K Sell
210
-121
-37% -$5.34K ﹤0.01% 1450
2023
Q4 		$14.2K Buy
+331
New +$10.5K ﹤0.01% 1447
2023
Q1 		– Sell
-1,471
Closed -$119K – 2039
2022
Q4 		$119K Buy
1,471
+800
+119% +$55.6K 0.01% 1076
2022
Q3 		$37K Buy
+671
New +$39.7K ﹤0.01% 1292
2022
Q2 		– Sell
-890
Closed -$73K – 2114
2022
Q1 		$73K Buy
890
+480
+117% +$45.7K 0.01% 1112
2021
Q4 		$61K Sell
410
-70
-15% -$12.5K ﹤0.01% 980
2021
Q3 		$90K Buy
480
+390
+433% +$74.2K 0.01% 987
2021
Q2 		$16K Buy
+90
New +$17.6K ﹤0.01% 1253

Other funds holding STRO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Quantbot Technologies's STRO Position: Q2 2024 in Review

Quantbot Technologies sold out of Sutro Biopharma (STRO) in Q2 2024, closing a stake of 210 shares — an estimated $11.9K sold.

Quantbot Technologies first reported a position in STRO in Q2 2021 and held it in 8 quarters. The position peaked at $119K in Q4 2022. 119 funds tracked by Wall St. Rank hold STRO as of Q2 2024.

  • Quantbot Technologies reported no remaining Sutro Biopharma position as of Q2 2024 after selling out during the quarter.
  • Quantbot Technologies sold 210 Sutro Biopharma shares in Q2 2024, an estimated $11.9K.
  • Quantbot Technologies first reported a position in Sutro Biopharma in Q2 2021 and held it in 8 quarters.
  • Quantbot Technologies's Sutro Biopharma position peaked at $119K in Q4 2022.
  • 119 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2024.

Based on Quantbot Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.